ClinicalTrials.gg
RecruitingNCT07724704Updated Jul 24, 2026

McGill Versus Sahrmann's Exercises for Chronic Non-Specific Low Back Pain

An interventional study of McGill Stabilization Exercise Protocol and Sahrmann's Exercise Protocol in Chronic Non-specific Low Back Pain, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 209 studies in Pain by Riphah International University — 86 open to participants now, 90 under way, none of them phase 3. Pain · Riphah International University.

Planned enrollment
88th of 207
40 · median 38
Started
2026
with 22 others
No phase
207 of 209
86 open now
Primary completion
2026-09
later than 70 of 89 live
Registered
198th of 209
by date

Among the 209 studies in Pain by Riphah International University, this one is the 88th largest by planned enrollment of the 207 interventional ones that give a count, is one of 23 that started in 2026, is one of 207 with no phase, reaches primary completion later than 70 of the 89 other live ones, and was the 198th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

86 of the 209 studies in Pain by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

80 more — sign in →

By country, each count listing its studies:

All 86 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 20 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 209 studies in Pain by Riphah International University, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare the effects of McGill stabilization exercises and Sahrmann's movement-based exercise protocol in adults with chronic non-specific low back pain. The study aims to determine which exercise program is more effective in reducing pain, improving lumbar range of motion, and decreasing functional disability.

The main questions it aims to answer are:

Do McGill stabilization exercises reduce pain, improve lumbar range of motion, and decrease disability in individuals with chronic non-specific low back pain? Are McGill stabilization exercises more effective than Sahrmann's movement-based exercise protocol in improving pain, lumbar range of motion, and functional disability?

Researchers will compare the McGill stabilization exercise group with the Sahrmann exercise group to determine which intervention provides greater improvements in clinical outcomes.

Participants will:

Be randomly assigned to either the McGill stabilization exercise group or the Sahrmann exercise group.

Receive baseline physiotherapy, including hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), lumbar isometric exercises, pelvic tilts, knee-to-chest exercises, and manual therapy.

Attend supervised treatment sessions 2-3 times per week for 6 weeks. Complete outcome assessments before and after treatment using the Numeric Pain Rating Scale (NPRS) for pain, the Oswestry Disability Index (ODI) for disability, and a bubble inclinometer to measure lumbar range of motion.

This study will provide evidence on the comparative effectiveness of two commonly used physiotherapy exercise protocols and help identify the most effective rehabilitation approach for managing chronic non-specific low back pain.

Read the detailed description

Chronic non-specific low back pain (CNSLBP) is one of the leading causes of disability worldwide and is associated with persistent pain, reduced spinal mobility, impaired motor control, and limitations in daily activities. Unlike specific low back pain, CNSLBP has no identifiable pathological cause, making rehabilitation through exercise therapy the primary treatment approach. Current clinical guidelines recommend exercise-based interventions to improve pain, function, and quality of life; however, there is no consensus regarding the most effective exercise protocol for individuals with chronic non-specific low back pain.

Among the commonly prescribed physiotherapy interventions are the McGill stabilization exercise program and Sahrmann's movement-based exercise protocol. The McGill approach focuses on enhancing spinal stability by improving core muscle endurance and minimizing excessive spinal loading through spine-sparing stabilization exercises. In contrast, Sahrmann's protocol emphasizes correction of movement impairments, restoration of normal lumbopelvic movement patterns, and activation of deep stabilizing muscles to improve motor control and functional movement.

Although both rehabilitation approaches have demonstrated beneficial effects when studied individually, direct comparative evidence regarding their effectiveness in improving pain, lumbar range of motion, and functional disability remains limited. Existing studies have primarily evaluated each intervention separately or compared them with conventional physiotherapy rather than with each other. Consequently, clinicians have limited evidence to guide the selection of the most appropriate exercise protocol for patients with chronic non-specific low back pain.

This randomized controlled trial is designed to compare the clinical effectiveness of McGill stabilization exercises and Sahrmann's movement-based exercise protocol in adults with chronic non-specific low back pain. Clinical outcomes will be evaluated using validated measures of pain intensity, lumbar range of motion, and functional disability before and after the intervention period. The findings are expected to clarify whether one exercise approach provides superior improvements in patient outcomes and functional recovery.

The results of this study will contribute to evidence-based physiotherapy practice by providing comparative evidence on two widely used rehabilitation protocols. Identifying the more effective intervention may assist physiotherapists in selecting appropriate exercise programs, improving clinical decision-making, optimizing rehabilitation outcomes, and supporting the development of standardized conservative management strategies for individuals with chronic non-specific low back pain.

03

Conditions studied

  • Chronic Non-specific Low Back Pain

Browse trials for

Keywords

  • Chronic Non-Specific Low Back Pain
  • McGill Stabilization Exercise Protocol
  • Sahrmann Exercise Protocol
  • Pain Intensity
  • Lumbar Range of Motion
  • Functional Disability
  • Core Stabilization Exercises
  • Numeric Pain Rating Scale (NPRS)
  • Oswestry Disability Index (ODI)
  • Bubble Inclinometer
04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 20-50 years.
  • Male and female participants.
  • Diagnosed with chronic non-specific low back pain lasting more than 12 weeks.
  • Pain intensity of 3-4 on the Numeric Pain Rating Scale (NPRS) at baseline.
  • Able and willing to participate in the exercise program and attend all treatment sessions.
  • Willing to provide written .

Exclusion criteria

Exclusion Criteria

  • History of spinal surgery.
  • Presence of neurological deficits.
  • Structural spinal deformities.
  • Pregnancy or within 6 months postpartum.
  • Presence of red flag signs or systemic illness (e.g., fracture, infection, , inflammatory disorders).
  • Individuals unable or unwilling to participate in the exercise program or complete the study protocol.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    McGill Stabilization Exercise Group

    Participants in this group will receive the McGill stabilization exercise protocol in addition to baseline physiotherapy. The exercise program is designed to improve core stability, spinal stability, lumbar range of motion, reduce pain, and improve functional ability in individuals with chronic non-specific low back pain. The intervention will be administered according to the study protocol for 6 weeks.

    Behavioral: McGill Stabilization Exercise Protocol

  • Experimental
    Sahrmann's Exercise Protocol Group

    Participants in this group will receive the Sahrmann's movement-based exercise protocol in addition to baseline physiotherapy. The program focuses on improving lumbopelvic control, correcting movement impairments, restoring normal movement patterns, reducing pain, increasing lumbar range of motion, and improving functional ability over a 6-week intervention period.

    Behavioral: Sahrmann's Exercise Protocol

Interventions

  • BehavioralMcGill Stabilization Exercise Protocol

    A progressive exercise program consisting of McGill stabilization exercises aimed at enhancing core muscle endurance, spinal stability, and neuromuscular control while reducing pain and improving lumbar function in individuals with chronic non-specific low back pain.

  • BehavioralSahrmann's Exercise Protocol

    A progressive movement-based exercise program designed to improve motor control, activate deep stabilizing muscles, correct faulty movement patterns, and enhance functional performance in individuals with chronic non-specific low back pain.

06

What researchers measure

Primary outcomes

  1. 1. Numeric Pain Rating Scale (NPRS)

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). The NPRS is a valid and reliable self-reported pain assessment tool that measures pain intensity on an 11-point scale ranging from 0 ("no pain") to 10 ("worst imaginable pain"). Participants will be asked to select the number that best represents their current pain intensity. A decrease in the NPRS score indicates an improvement in pain following the intervention.

    Time frame: [Time Frame: 6 Weeks]

  2. 2. Oswestry Disability Index (ODI)

    Functional disability will be assessed using the Oswestry Disability Index (ODI). The ODI is a disease-specific, validated questionnaire used to evaluate disability associated with chronic low back pain. It consists of 10 sections covering pain intensity, personal care, lifting, walking, sitting, standing, sleeping, social life, travelling, and employment/homemaking. Each section is scored from 0 to 5, with higher total scores indicating greater disability. A reduction in the ODI score reflects improvement in functional status and daily activities.

    Time frame: [Time Frame: 6 Weeks]

Secondary outcomes

  1. 3. Bubble Inclinometer

    Lumbar range of motion (ROM) will be measured using a bubble inclinometer, a reliable and valid instrument for assessing spinal mobility. Measurements will be obtained for lumbar flexion, extension, right and left lateral flexion, and right and left rotation according to standardized measurement procedures. The bubble inclinometer provides objective assessment of lumbar spinal movement in degrees. An increase in lumbar range of motion indicates improvement following the intervention.

    Time frame: [Time Frame: 6 Weeks]

07

Study locations

1 of 1 sites recruiting
  • Lahore Clinic Shujabad, THQ Hospital Shujabad
    Lahore, Punjab Province 60000, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Sep 2026, 2 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 24, 2026
StartActual
Jul 16, 2026
Primary completionEst.
Sep 16, 2026
CompletionEst.
Sep 16, 2026
Last update
Jul 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07724704
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
Jul 16, 2026
Primary completion
Sep 16, 2026 (estimated)
Completion
Sep 16, 2026 (estimated)
Last update
Jul 24, 2026

Study contacts

Imran Amjad, Phd
Contact
imran.amjad@riphah.edu.pk
03324390125
Annum Manzoor, MS OMPT
principal investigator · Gulab Devi Teaching institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion